Single-cell Multi-omics reveal heterogeneity and metastasis potential in different liver cancer cell lines
L. Wu, J. Xie, S. Wang, X. Zou, T. Pan, Z. Zhuang, Z. WangiD, Y. Yuan, L. Liu, S. Liu
Abstract
Hepatocellular carcinoma (HCC) is a malignant neo-plasm with a high recurrence and metastatic rate, accounted for poor prognosis. Commonly existed heterogeneity is concerned with neoplasia, cancer progression, therapeutic resistance and metastasis is the principal cause of cancer lethality. As development of multi-omics methods in single-cell technology provides multi-faceted insight into disease processes in the era of precision medicine. Here, we interrogated single-cell transcriptomes, proteomes and epigenetic information, revealing metastasis potential heterogeneity in 5 HCC cell lines across different metastasis capacity. We confirmed that higher mesenchymal (M) status but not proliferation rate was associated with stronger metastasis ability of cell lines. Besides, we identified a subgroup being common in several cell lines, showing a higher hypoxic signature. A gene set involving 14 genes were chosen to represent the hypoxia state, much consistent than previous reported gene set, and showed worse prognosis association in TCGA data. This hypoxic subgroup prefers glycolysis metabolism than OXPO, and showed non-cycling, quiescent state which could be resistant to many proliferation-targeting drugs. Our results provide a comprehensive understanding of characteristic associated with metastasis capacity of HCC cell line, which will guide the metastasis mechanism study of HCC.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A novel hypoxia gene signature indicates prognosis and reveals the multi-omics molecular landscape of tumour tissue in patients with hepatocellular carcinoma
Qiangnu Zhang, Juan Liao, … Liping Liu·bioRxiv·Jul 10, 2020
- Decoding Liver Cancer Prognosis: From Multi-omics Subtypes, Prognostic Models to Single Cell Validation
Yanbin Wang, Yuqi Wu, … Yanmei Zou·bioRxiv·Nov 4, 2024
- Hepatic stellate cells drive hypoxia-inducible factor (HIF)-dependent metabolic rewiring and proliferation in hepatocellular carcinoma cells
Demi J. Rijlaarsdam, Jung‐Chin Chang, … Celia R. Berkers·bioRxiv·Oct 28, 2026
- Patient-derived HCC cells recapitulating the transcriptomic landscape of primary HCV-related liver cancer
Janine Kah, Lisa Staffeldt, … Stefan Lüth·bioRxiv·Dec 1, 2024
- Metastatic potentials classified with hypoxia-inducible factor 1 downstream gene in pan-cancer cell lines
K. Nakamichi, K. Semba, J. Nakayama·bioRxiv·May 8, 2023
- Metastatic signaling of hypoxia-related genes across TCGA Pan-Cancer types
A. Lopez-Cortes, P. Guevara-Ramirez, … C. Paz-y-Mino·bioRxiv·Feb 1, 2020